Abacus Planning Group, Inc. Prime Medicine, Inc. Transaction History
Abacus Planning Group, Inc.
- $667 Million
- Q3 2025
A detailed history of Abacus Planning Group, Inc. transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Abacus Planning Group, Inc. holds 25,188 shares of PRME stock, worth $161,958. This represents 0.02% of its overall portfolio holdings.
Number of Shares
25,188Holding current value
$161,958% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding PRME
# of Institutions
132Shares Held
56.1MCall Options Held
182KPut Options Held
211K-
Alphabet Inc. Mountain View, CA15.1MShares$96.9 Million2.41% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.48MShares$41.7 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.11MShares$32.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.63MShares$23.3 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.32MShares$14.9 Million0.05% of portfolio
About Prime Medicine, Inc.
- Ticker PRME
- Shares Outstandng 95,730,200
- Market Cap $616M